Daily Bulletin

Men's Weekly

.

US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

Key Highlights:

  • US FDA has cleared Cynata's IND application for a Phase 2 clinical trial of CYP-001 in patients with aGvHD – a major milestone and value catalyst for the Company
  • Phase 2 clinical study in aGvHD expected to commence subsequent to customary and satisfactory completion of negotiations with study centres and receipt of relevant...

Read more: US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD

Business News

Workplace Health Checks: A Smart Investment for Small Business Success

Running a small business means every team member counts and when poor health leads to absenteeism or low energy, productivity and profits take a hit. Lost workdays, rising healthcare costs, and staff ...

Daily Bulletin - avatar Daily Bulletin

Rising Demand: Why Melbourne Needs More Electricians Now

Melbourne is running on change. Rooftops are filling with solar, carports are getting charge points, and older switchboards are being rebuilt so homes and shops can carry smarter, heavier loads. If yo...

Daily Bulletin - avatar Daily Bulletin

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals